Statement Of Cash Flows [Abstract]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for interest expense
271,555 GBP
315,991 GBP
Adjustments for interest income
23,164 GBP
85,344 GBP
Adjustments for depreciation expense
639,285 GBP
645,681 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.